Vamousse Lice Treatment Aerosol, Foam
NDC Package 72238-001-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Vamousse Lice Treatment (pediculicide) aerosols is a medication used to treat dryness inside the nose (nasal passages). This formulation utilizes a aerosol, foam delivery system. Marketed by Alliance Pharma Inc., this product is identified by NDC 72238-001.

Identification & Billing

NDC Package Code
72238-001-01
Package Description
1 BOTTLE, WITH APPLICATOR in 1 BOX / 177 mL in 1 BOTTLE, WITH APPLICATOR
Product Code
72238-001
11-Digit Billing Format
72238000101

Clinical Specifications

Proprietary Name
Vamousse Lice Treatment
Non-Proprietary Name
Pediculicide
Substance Name
Sodium Chloride
Dosage Form
Aerosol, Foam - A dosage form containing one or more active ingredients, surfactants, aqueous or nonaqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
SODIUM CHLORIDE 2 [hp_X]/mL
Pharmacologic Class
Usage Information
This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.

Regulatory & Marketing

Labeler Name
Alliance Pharma Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
10-01-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72238-001-01 identifies a specific commercial package of 1 bottle, with applicator in 1 box / 177 ml in 1 bottle, with applicator of Vamousse Lice Treatment, a human over the counter drug labeled by Alliance Pharma Inc.. This aerosol, foam is formulated for topical use and contains sodium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alliance Pharma Inc. on October 01, 2018. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.

How is this Alliance Pharma Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72238000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72238-001-01
11-Digit CMS (5-4-2)
72238-0001-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.